Skip to content
‹ Back to IndustriesSciences

How Basic Chemicals are Being Impacted in the Supply Chain

Key Points: Supply Chain Issues are causing disruptions to the chemical industry. Ethylene, PVC, and epoxy resins are seeing price surges to the disruptions. The big players figured out how to deal with disruptions in the supply chain. Commentary: Disruptions in the supply chain are causing problems across every industry. Basic chemicals, such as…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Basic ChemicalsChemical Supply ChainPrice SurgePvc
Share

Key takeaways

01

Key Points: Supply Chain Issues are causing disruptions to the chemical industry.

02

Ethylene, PVC, and epoxy resins are seeing price surges to the disruptions.

03

The big players figured out how to deal with disruptions in the supply chain.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Key Points:

  • Supply Chain Issues are causing disruptions to the chemical industry.
  • Ethylene, PVC, and epoxy resins are seeing price surges to the disruptions.
  • The big players figured out how to deal with disruptions in the supply chain.

Commentary:

Disruptions in the supply chain are causing problems across every industry. Basic chemicals, such as ethylene, PVC, and epoxy resins, are seeing price surges due to these disruptions. We asked Jimmy Jett, CEO of Integrity BioChem, about these demand increases and what sort of role does it play in the overall chemical supply chain issue.

Abridged Thoughts:

Obviously, demand. There is a lot of pent-up demand from the pandemic, as people start to consume more and get back on the roads and travel. You’re seeing a lot of demand. It is unfortunate that demand is spiking, as supply is dwindling. What you’re seeing is that the big players have more sophisticated supply chain systems and have gotten out ahead of it. Some great examples are you’ve seen some of the bigger companies that have even contracted their own fleet to move goods and services around the world. You’re seeing some of the larger players with a really solid plan to mitigate some of the supply chain issues, but the Tier Two and Three companies might not have the cash flow to go out and purchase six months worth of inventory. 

What Can the Pharma Industry Learn from Merck’s New Antiviral?

Will Consumers Be Seeing Higher Prices as the Result of the Tightened Supply Chain?

Video TranscriptExpand ↓

Disruptions in the supply chain are causing problems across every industry. Basic chemicals such as ethylene, PVC and epoxy resins are seeing price surges due to these disruptions. With that in mind, we asked Jimmy, CEO of integrity biochim. About this increases in the man and what sort of role does it play in the overall chemical supply chain issue? You know, obviously demand there's a lot of pent up demand from the pandemic as people start to consume more and get back on the roads and travel. You're seeing a lot of demand, and it's unfortunate that demand is spiking as supply is dwindling. So what you're seeing is the big players that have a more sophisticated supply chain system have gotten out ahead of it. Some great examples or you've seen a lot of the bigger companies that have even contracted their own fleet to move goods and services around the world. And so you're seeing some of the larger players with a really solid plan to mitigate a lot of the supply chain issues. But the tier two and tier three companies that might not have the cash flow to go out and purchase six months worth of inventory are feeling it the most and you're going to see. And then the reality is in the US that tier two and tier three support system in manufacturing than in the chemical space that goods and services, it makes up a massive percentage of the market. So you're going to see a very compressed manufacturing base that are able to get the products. And so with that are going to come a lot of delays. You can just expect, you know, lead times to go from 2 to three weeks to six months and even pushed out further. So it's going to be interesting as the market tries to correct. We already know what these issues are doing to chemicals such as ethylene, PVC and epoxy resins. But what about the sustainable, bio based chemicals? Are they being impacted similarly or in a completely different way? So the sustainable supply chain, you know, the surfactants or the based surfactants and the chemical side have not been impacted. But what you're going to find is that a lot of the technology out there, you obviously don't have the production capacity that is built into their traditional synthetic market. So a lot of the fermentation capacity has come a long way and you're going to see them surge over the next six months because they're going to be able to produce what they can. However, what they can produce is just a fraction of what the industry needs. A lot of the vegetative sources like integrity biochem uses, they're going to be more readily available as well, but they're emerging technologies and they might not have the adoption that traditional synthetics have. So it's going to be interesting to see how quickly you can get these chemistries into the supply chain and through the regulatory side in an expedited way to make an impact. Finding solutions to these supply chain issues is something every industry is trying to figure out when it comes to chemical producers. What strategies should they implement westjet? Should they be investing in New supply chain partnerships, new chemical compounds or new production workflows? And this is what he had to say. I think it's definitely a mix. I mean, you have to be looking at alternative supply partners immediately to secure the pent up demand that is required to run your business. But, you know, in a congruent path, you need to be also looking at New technologies that might supplement or even replace some of these existing technologies. You know, one of the things I love about this industry is that innovation is born in difficult supply markets. When there's challenges out there, a lot of new stuff is developed and a lot of new markets are created. So I'm excited to see what happens. I mean, America is we are excellent at adapting. And so I think we're going to see a lot of neat new technologies emerge and a lot of sustainable products that might have been on the sidelines are going to have a shot to come in and replace some of the sympathetics that you just can't get right now. Chemical energy and its demands is something that needs to be closely evaluated, especially when it's in high demand and a supply chain process is facing as many issues as it is. For more stories of energy and its supply chain effects, be sure to head to Marcus gmail.com as well as subscribe.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Takara Bio and SPT Labtech pair SMART-Seq kits with firefly automation scripts

Takara Bio and SPT Labtech pair SMART-Seq kits with firefly automation scripts

SPT Labtech and Takara Bio USA are teaming up to offer validated, automated workflows for library preparation, pairing Takara Bio's NGS library prep chemistries with the firefly liquid handler from SPT Labtech. Two SMART-Seq kits are available for download today. Due to ship in January 2027, the SMART-Seq mRNA Long Read Extended kit is set to be the first product to launch with a workflow tuned for firefly automation.

  • 01For sequencing cores on SPT Labtech's firefly, Takara Bio says automated workflows will be built into new kits from the start, which suggests more of the method-building could happen at the vendors before the box reaches the bench.
  • 02Whether DNA-seq and immune profiling kits arrive with firefly scripts on their launch dates will show if this becomes standard practice or stays an RNA-seq offering.

Nov 3, 2026

Crown Bioscience Appoints Guy Sheets as Senior Vice President, Commercial

Crown Bioscience appointed Guy Sheets as Senior Vice President, Commercial, bringing over 30 years of pharma and life sciences experience to lead the CRO's global commercial strategy. Sheets previously held senior commercial roles at QPS Holdings, CenExel, SGS Health Sciences, Lonza, and Thermo Fisher Scientific.

  • 01Guy Sheets brings 30+ years of commercial leadership across pharma, biotech, and life sciences, most recently as VP, Head of Global Business Development at QPS Holdings
  • 02Crown Bioscience operates 9 facilities across the US, Europe, and APAC with a portfolio of 2,800+ patient-derived xenograft models and 1,000+ tumor organoid models across 35 cancer indications
  • 03Sheets will lead Crown Bioscience’s global commercial strategy to drive growth, expand market presence, and strengthen client partnerships

Nov 3, 2026

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck's €300 million Korean plant brings biologics supplies closer to Asia-Pacific drugmakers

Merck has invested more than €300 million in a new bioprocessing production center in Daejeon, South Korea. It is the largest life science investment Merck has made in the region to date. The 44,500-square-meter facility makes cell culture media, process liquids and sterile sampling products to support biologics manufacturing from development through commercial supply.

  • 01A single Asia-Pacific site now supplies both small custom pre-GMP media and commercial-scale media, so a regional biologics program could scale without switching to a source outside the region.
  • 02Daejeon supplies cell culture media, process liquids, ready-to-use cleaning-in-place solutions and sterile sampling products.
  • 03The useful supplier question has moved past whether Merck has an Asia-Pacific plant: ask which product lines ship from Daejeon and what batch traceability data customers can see.

Nov 3, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512